EBACW
European Biotech Acquisition Corp. [EBACW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
EBACW Stock Summary
In the News
EBACW Financial details
Company Rating
-
Market Cap
0
Income
3.5M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-257.13
Forward P/E
-
PEG
48.05
P/S
-
P/B
1.18
P/C
-
P/FCF
4043.19
Quick Ratio
0.39
Current Ratio
0.45
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.2
EPS next Y
-
EPS next Q
-
EPS this Y
-37.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-561.07%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-0.02%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.5-0.5499
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
18.33K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-6.36%
-
-
-
-
Beta
-
-
-
Volatility
0.02%, 0.02%
Prev Close
0%
Price
0.515
Change
-39.49%
Company Profile
- CEO Mr. Eduardo Bravo Fernandez de Araoz
- Headquarters Amsterdam,NL
- IPO Date 2021-05-11
European Biotech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2021 and is based in Amsterdam, the Netherlands.
